Reblood RX, Inc.
San Diego, CA
- UEI
- Y3YHZCHJ3285
- CAGE
- 9JBK7
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 8643 Anrol Ave, San Diego, CA 92123, USA
- Website
- rebloodrx.com
- Founded
- 2023
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $74,881 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Air Force | $74,881 |
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Hemoglobin solution to improve hemorrhagic shock treatment for combat medics | Air Force Research Laboratory (AFMC) | $74,881 |
Quick answers
Is Reblood RX, Inc. registered in SAM.gov?
Yes. Reblood RX, Inc.'s SAM.gov registration is active through May 6, 2027.
How much has Reblood RX, Inc. received in federal contracts?
Federal contracts obligated $74,881 to Reblood RX, Inc. in fiscal years 2023 through 2027.
What is Reblood RX, Inc.'s most recent federal award?
Reblood RX, Inc.'s most recent federal contract award is Hemoglobin solution to improve hemorrhagic shock treatment for combat medics (FA864926P0099), from Air Force Research Laboratory (AFMC), on July 13, 2026.
On GovTribe
See Reblood RX, Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors